James S Scibetta's Net Worth
$14.9 Million
Who is James S Scibetta?
James S Scibetta has an estimated net worth of $14.9 Million. This is based on reported shares across multiple companies, which include Matinas BioPharma Holdings, Inc., Pacira Pharmaceuticals, Inc., NEPHROS INC, Aquestive Therapeutics, Inc., and BIOENVISION INC.
SEC CIK
James S Scibetta's CIK is 0001383242
Past Insider Trading and Trends
2019 was James S Scibetta's most active year for acquiring shares with 10 total transactions. James S Scibetta's most active month to acquire stocks was the month of May. 2014 was James S Scibetta's most active year for disposing of shares, totalling 14 transactions. James S Scibetta's most active month to dispose stocks was the month of October. 2015 saw James S Scibetta paying a total of $331,000.00 for 60,000 shares, this is the most they've acquired in one year. In 2016 James S Scibetta cashed out on 90,000 shares for a total of $1,860,250.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +4.64% | 28.8K |
—
|
—
| 649.96K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +0.58% | 3.6K |
—
|
—
| 621.16K |
Jun 23
| |||
Form 4
| +1.36% | 8.26K |
—
|
—
| 617.56K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +5.57% | 32.14K |
—
|
—
| 609.3K |
Jun 21 - Sep 30
| |||
Form 4
| +3.94% | 21.88K |
—
|
—
| 577.16K |
Jun 30
| |||
Form 4
| +3.20% | 17.2K |
—
|
—
| 555.28K |
Mar 31
| |||
Form 4
| +6.22% | 31.51K |
—
|
—
| 538.08K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +4.19% | 20.38K |
—
|
—
| 506.56K |
Oct 1
| |||
Form 4
| +9.75% | 43.2K |
—
|
—
| 486.18K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +5.90% | 24.67K |
—
|
—
| 442.98K |
Mar 30
| |||
Form 4
| +1.21% | 5K |
$1.29 | $6,450.00 | 418.31K |
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira Pharmaceuticals, Inc. (PCRX) Snapshot price: $13.89
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.26% | -1.97K |
$43.32 | -$85,169.09 | 25.12K |
Jun 5
| |||
Form 4
|
—
|
0
|
$28.35 | -$914,200.00 | 27.08K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
$21.78 | -$670,105.50 | 27.08K |
Scheduled
|
Jan 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
$19.06 | -$697,800.00 | 27.08K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$23.41 | -$1,090,000.00 | 27.08K |
Scheduled
|
Aug 15
| ||
Form 4
| +154.70% | 16.25K |
—
|
—
| 26.75K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
| +90.84% | 5K |
$61.37 | $306,850.00 | 10.5K |
Sep 11
| |||
Form 4
|
—
|
0
|
$56.42 | -$1,644,224.19 | 5.23K |
Scheduled
|
Feb 6
| ||
Form 4
|
—
|
0
|
$44.40 | -$1,283,492.00 | 5K |
Scheduled
|
Nov 7
| ||
Form 4
|
—
|
0
|
$50.62 | -$1,470,250.00 | 5K |
Scheduled
|
Aug 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
$38.33 | -$1,101,531.00 | 5K |
Scheduled
|
May 8
| ||
Form 4
|
—
|
0
|
$28.58 | -$539,400.00 | 5K |
Scheduled
|
Dec 30
| ||
Form 4
|
—
|
0
|
$24.18 | -$451,300.00 | 5K |
Scheduled
|
Sep 30
| ||
Form 4
|
—
|
0
|
$14.83 | -$264,360.00 | 5K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$15.05 | -$268,800.00 | 5K |
Scheduled
|
Mar 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 5K |
$7.04 | $35,200.00 | 5K |
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEPHROS INC (NEPH) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +23.20% | 12.08K |
—
|
—
| 64.13K |
Aug 20
| |||
Form 4
|
∞
| 52.06K |
—
|
—
| 52.06K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $4.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +265.13% | 22.97K |
$3.79 | $86,977.07 | 31.64K |
Aug 19 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOENVISION INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||